title: Drugs for pre-osteoporosis: prevention or disease mongering?
authors.affiliation: Iberoamerican Cochrane Center, Department of Clinical Epidemiology and Public Health, Hospital de Sant Pau, Universidad Autónoma de Barcelona, 08041, Barcelona, Spain. palonso@santpau.es
authors.forename: Pablo
authors.initials: P
authors.lastname: Alonso-Coello
authors.forename: Alberto López
authors.initials: AL
authors.lastname: García-Franco
authors.forename: Gordon
authors.initials: G
authors.lastname: Guyatt
authors.forename: Ray
authors.initials: R
authors.lastname: Moynihan
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016265:Conflict of Interest; D005260:Female; D006801:Humans; D008389:Marketing of Health Services; D015201:Meta-Analysis as Topic; D010024:Osteoporosis / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents